Daniel Breadner
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma. (NCT07348107) | Daniel Breadner | 2026-02-15 |
Track Daniel Breadner automatically
Every clearance here is in the API, with alerts when new ones post.